ENVB:NASDAQEnveric Biosciences, Inc. Analysis
Data as of 2026-09-23 - not real-time
$1.56
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Enveric Biosciences, Inc. trades at $1.55, with its moving averages tangled rather than clearly stacked — a neutral trend structure. RSI sits at 57.7, which reads as neutral, and MACD momentum is bullish. Watch $1.17 as support and $1.65 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 55.4%, a beta of 1.35 and a maximum drawdown of 88.2%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 55.4%, a beta of 1.35 and a maximum drawdown of 88.2%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Top Market Events
Updated Sep 1, 2026 0 CAMBRIDGE, Mass.-- BUSINESS WIRE --Sep 1, 2026-- Enveric Biosciences NASDAQ: ENVB “Enveric”...Morningstar%2c Inc.1monEnveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug DevelopmentFDA guidance...Yahoo Finance22dEnveric Biosciences to Present at H.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 2.51
- MACD momentum is positive
- 30-day volatility of 55.4%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 2.51
- 30-day volatility of 55.4%
- MACD momentum is positive
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Negative return on equity of -170.0%
- Negative free cash flow
- 30-day volatility of 55.4%
Key Metrics & Analysis
Financial Health
P/E Ratio-1.1
ROE-170.04%
ROA-87.34%
P/B Ratio0.8
Op. Cash Flow$-8561197
Free Cash Flow$-5202416
Industry P/E30.1
Technical Analysis
TrendNeutral
RSI57.7
Support$1.17
Resistance$1.65
MA 20$1.45
MA 50$1.44
MA 200$2.51
MACDBullish
VolumeStable
Fear & Greed Index94.75
Valuation
GradeFair
TypeBlend
Risk Assessment
Beta1.35
Volatility55.42%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.